Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 27 | 2024 | 201 | 9.090 |
Why?
|
| Liver Transplantation | 15 | 2024 | 1033 | 2.570 |
Why?
|
| Bilirubin | 6 | 2023 | 126 | 2.550 |
Why?
|
| Neonatal Screening | 6 | 2021 | 187 | 2.440 |
Why?
|
| Jaundice | 3 | 2023 | 28 | 2.000 |
Why?
|
| Portoenterostomy, Hepatic | 10 | 2024 | 55 | 1.680 |
Why?
|
| Cholestasis | 5 | 2024 | 161 | 1.490 |
Why?
|
| Jaundice, Neonatal | 2 | 2022 | 13 | 1.290 |
Why?
|
| Liver Diseases | 4 | 2022 | 384 | 0.990 |
Why?
|
| Choledocholithiasis | 1 | 2022 | 15 | 0.820 |
Why?
|
| Infant | 23 | 2024 | 12304 | 0.790 |
Why?
|
| Infant, Newborn | 15 | 2024 | 8096 | 0.780 |
Why?
|
| Liver | 8 | 2023 | 1851 | 0.720 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 103 | 0.700 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 174 | 0.700 |
Why?
|
| Fractures, Multiple | 1 | 2019 | 3 | 0.690 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 218 | 0.600 |
Why?
|
| Premature Birth | 1 | 2022 | 380 | 0.590 |
Why?
|
| Early Diagnosis | 1 | 2018 | 178 | 0.580 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2017 | 67 | 0.560 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 121 | 0.550 |
Why?
|
| Retina | 5 | 2008 | 457 | 0.530 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 580 | 0.490 |
Why?
|
| Humans | 45 | 2024 | 122120 | 0.490 |
Why?
|
| Hypertension, Portal | 3 | 2021 | 80 | 0.470 |
Why?
|
| Hypopituitarism | 1 | 2014 | 15 | 0.460 |
Why?
|
| Graft Rejection | 1 | 2017 | 578 | 0.450 |
Why?
|
| Glucocorticoids | 2 | 2016 | 379 | 0.450 |
Why?
|
| Matrix Metalloproteinase 7 | 3 | 2024 | 21 | 0.450 |
Why?
|
| Platelet Activating Factor | 1 | 2012 | 29 | 0.420 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 17 | 0.410 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 49 | 0.410 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 53 | 0.410 |
Why?
|
| Endoscopy, Digestive System | 1 | 2012 | 154 | 0.380 |
Why?
|
| Taeniasis | 1 | 2010 | 3 | 0.350 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 239 | 0.350 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 237 | 0.330 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 2009 | 0.310 |
Why?
|
| Chickens | 2 | 2006 | 637 | 0.300 |
Why?
|
| Thyroid Hormones | 2 | 2008 | 66 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2010 | 132 | 0.290 |
Why?
|
| Child | 16 | 2024 | 24049 | 0.280 |
Why?
|
| Biomarkers | 5 | 2024 | 2939 | 0.280 |
Why?
|
| End Stage Liver Disease | 2 | 2021 | 178 | 0.260 |
Why?
|
| Bile Acids and Salts | 3 | 2023 | 236 | 0.260 |
Why?
|
| Retroviridae | 1 | 2006 | 205 | 0.250 |
Why?
|
| Retrospective Studies | 12 | 2024 | 15856 | 0.250 |
Why?
|
| Female | 16 | 2024 | 64764 | 0.250 |
Why?
|
| Live Birth | 2 | 2022 | 54 | 0.240 |
Why?
|
| RNA Interference | 1 | 2006 | 496 | 0.230 |
Why?
|
| Male | 15 | 2024 | 59429 | 0.220 |
Why?
|
| Infant Formula | 1 | 2024 | 98 | 0.220 |
Why?
|
| Airway Extubation | 1 | 2024 | 67 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2019 | 1003 | 0.220 |
Why?
|
| Adolescent | 7 | 2024 | 18929 | 0.220 |
Why?
|
| Hepatic Duct, Common | 1 | 2023 | 9 | 0.220 |
Why?
|
| Liver Cirrhosis | 5 | 2023 | 824 | 0.220 |
Why?
|
| Cholangitis | 1 | 2023 | 35 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 2076 | 0.210 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2022 | 37 | 0.210 |
Why?
|
| Hyperbilirubinemia | 1 | 2022 | 43 | 0.200 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 47 | 0.200 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 82 | 0.200 |
Why?
|
| Epithelium | 1 | 2023 | 372 | 0.200 |
Why?
|
| Hepatitis | 1 | 2022 | 65 | 0.200 |
Why?
|
| Milk, Human | 1 | 2024 | 295 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 88 | 0.190 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 453 | 0.180 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 187 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 126 | 0.180 |
Why?
|
| Abdominal Pain | 1 | 2023 | 308 | 0.180 |
Why?
|
| Antioxidants | 1 | 2022 | 337 | 0.170 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 140 | 0.170 |
Why?
|
| Gastroenteritis | 1 | 2023 | 332 | 0.170 |
Why?
|
| Pregnancy | 3 | 2022 | 7092 | 0.170 |
Why?
|
| Perioperative Care | 1 | 2021 | 195 | 0.160 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2019 | 33 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 189 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 269 | 0.160 |
Why?
|
| Reference Values | 1 | 2020 | 694 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2023 | 907 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 479 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 283 | 0.150 |
Why?
|
| Prevalence | 2 | 2022 | 2366 | 0.150 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2016 | 106 | 0.150 |
Why?
|
| Iodide Peroxidase | 2 | 2008 | 8 | 0.150 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 41 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2021 | 455 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1711 | 0.140 |
Why?
|
| Rituximab | 1 | 2017 | 157 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2021 | 941 | 0.140 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 20 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1277 | 0.130 |
Why?
|
| Critical Care | 1 | 2021 | 647 | 0.130 |
Why?
|
| Inflammation | 1 | 2023 | 1391 | 0.130 |
Why?
|
| Age Factors | 2 | 2020 | 2774 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2023 | 1521 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1005 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 392 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 230 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 239 | 0.120 |
Why?
|
| Young Adult | 2 | 2023 | 8772 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1293 | 0.120 |
Why?
|
| Aged | 2 | 2023 | 18735 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2018 | 524 | 0.120 |
Why?
|
| Adult | 3 | 2023 | 28676 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 335 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2024 | 13781 | 0.110 |
Why?
|
| Penis | 1 | 2014 | 96 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 962 | 0.110 |
Why?
|
| Physical Examination | 1 | 2014 | 163 | 0.100 |
Why?
|
| Pentoxifylline | 1 | 2012 | 20 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2024 | 2997 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2012 | 82 | 0.100 |
Why?
|
| Chick Embryo | 3 | 2008 | 131 | 0.100 |
Why?
|
| Treatment Outcome | 6 | 2024 | 12020 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 237 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3296 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 278 | 0.090 |
Why?
|
| Time Factors | 3 | 2018 | 6168 | 0.090 |
Why?
|
| United States | 3 | 2021 | 10459 | 0.090 |
Why?
|
| Prognosis | 3 | 2024 | 4484 | 0.090 |
Why?
|
| Risk Factors | 5 | 2024 | 9864 | 0.090 |
Why?
|
| Ileum | 1 | 2010 | 134 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2008 | 427 | 0.080 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 84 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 769 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2012 | 799 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2010 | 1165 | 0.060 |
Why?
|
| Body Patterning | 1 | 2005 | 122 | 0.060 |
Why?
|
| Tretinoin | 1 | 2005 | 117 | 0.060 |
Why?
|
| Parents | 2 | 2023 | 1013 | 0.060 |
Why?
|
| Animals | 7 | 2022 | 33724 | 0.060 |
Why?
|
| Amphibians | 1 | 2003 | 3 | 0.060 |
Why?
|
| Rodentia | 1 | 2003 | 46 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 36 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3865 | 0.050 |
Why?
|
| Middle Aged | 1 | 2023 | 25538 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 1158 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2024 | 176 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 22 | 0.050 |
Why?
|
| Aldehydes | 1 | 2022 | 28 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 175 | 0.050 |
Why?
|
| Mice | 4 | 2022 | 17552 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2006 | 2826 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 795 | 0.050 |
Why?
|
| Viremia | 1 | 2022 | 128 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 209 | 0.050 |
Why?
|
| Genome | 1 | 2004 | 472 | 0.050 |
Why?
|
| Base Sequence | 1 | 2006 | 3109 | 0.050 |
Why?
|
| Homozygote | 1 | 2023 | 521 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 228 | 0.050 |
Why?
|
| Bile | 1 | 2020 | 47 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2023 | 637 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1107 | 0.040 |
Why?
|
| Autophagy | 1 | 2022 | 390 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 1090 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1272 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 1437 | 0.040 |
Why?
|
| Exome | 1 | 2023 | 1012 | 0.040 |
Why?
|
| Intestinal Atresia | 1 | 2017 | 19 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1467 | 0.040 |
Why?
|
| Esophageal Atresia | 1 | 2017 | 51 | 0.040 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2017 | 48 | 0.040 |
Why?
|
| Critical Illness | 1 | 2021 | 588 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 7 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2023 | 3228 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 123 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 207 | 0.030 |
Why?
|
| Caregivers | 1 | 2021 | 561 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 4984 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 381 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 348 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2015 | 98 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4633 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 403 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 663 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 515 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 346 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 303 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 5965 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2014 | 220 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 581 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1462 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 610 | 0.030 |
Why?
|
| Stem Cells | 2 | 2008 | 710 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1368 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 498 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2782 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 1992 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3074 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 711 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3771 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 261 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4366 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 196 | 0.020 |
Why?
|
| Receptor, EphB3 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2005 | 19 | 0.020 |
Why?
|
| Receptor, EphB2 | 1 | 2005 | 8 | 0.020 |
Why?
|
| Avian Proteins | 1 | 2005 | 11 | 0.020 |
Why?
|
| Ephrin-B2 | 1 | 2005 | 9 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 101 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 78 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 61 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4511 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 211 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 239 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 474 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 219 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 386 | 0.010 |
Why?
|
| Interneurons | 1 | 2004 | 138 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 542 | 0.010 |
Why?
|
| Neuroglia | 1 | 2004 | 192 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 348 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 463 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1790 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1067 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 680 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1934 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 789 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 2535 | 0.010 |
Why?
|